These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study. Gulmez SE; Holm A; Frederiksen H; Jensen TG; Pedersen C; Hallas J Arch Intern Med; 2007 May; 167(9):950-5. PubMed ID: 17502537 [TBL] [Abstract][Full Text] [Related]
3. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A; Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285 [TBL] [Abstract][Full Text] [Related]
4. Risk of community-acquired pneumonia in veteran patients to whom proton pump inhibitors were dispensed. Hermos JA; Young MM; Fonda JR; Gagnon DR; Fiore LD; Lawler EV Clin Infect Dis; 2012 Jan; 54(1):33-42. PubMed ID: 22100573 [TBL] [Abstract][Full Text] [Related]
5. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding. Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493 [TBL] [Abstract][Full Text] [Related]
6. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. Laheij RJ; Sturkenboom MC; Hassing RJ; Dieleman J; Stricker BH; Jansen JB JAMA; 2004 Oct; 292(16):1955-60. PubMed ID: 15507580 [TBL] [Abstract][Full Text] [Related]
7. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites. Bajaj JS; Zadvornova Y; Heuman DM; Hafeezullah M; Hoffmann RG; Sanyal AJ; Saeian K Am J Gastroenterol; 2009 May; 104(5):1130-4. PubMed ID: 19337238 [TBL] [Abstract][Full Text] [Related]
8. Community-acquired pneumonia requiring hospitalisation. Factors of importance for the short-and long term prognosis. Hedlund J Scand J Infect Dis Suppl; 1995; 97():1-60. PubMed ID: 8584866 [TBL] [Abstract][Full Text] [Related]
9. Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada. Rahme E; Barkun A; Nedjar H; Gaugris S; Watson D Am J Gastroenterol; 2008 Apr; 103(4):872-82. PubMed ID: 18371130 [TBL] [Abstract][Full Text] [Related]
10. Meta-analysis: proton pump inhibitor use and the risk of community-acquired pneumonia. Johnstone J; Nerenberg K; Loeb M Aliment Pharmacol Ther; 2010 Jun; 31(11):1165-77. PubMed ID: 20222914 [TBL] [Abstract][Full Text] [Related]
11. COX-2 inhibitors: complex association with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors. van der Linden MW; Gaugris S; Kuipers EJ; van Herk-Sukel MP; van den Bemt BJ; Sen SS; Herings RM Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):880-90. PubMed ID: 19593747 [TBL] [Abstract][Full Text] [Related]
12. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Howell MD; Novack V; Grgurich P; Soulliard D; Novack L; Pencina M; Talmor D Arch Intern Med; 2010 May; 170(9):784-90. PubMed ID: 20458086 [TBL] [Abstract][Full Text] [Related]
13. Inhaled corticosteroids and risk of recurrent pneumonia: a population-based, nested case-control study. Eurich DT; Lee C; Marrie TJ; Majumdar SR Clin Infect Dis; 2013 Oct; 57(8):1138-44. PubMed ID: 23872948 [TBL] [Abstract][Full Text] [Related]
14. Microbial evaluation of proton-pump inhibitors and the risk of pneumonia. Meijvis SC; Cornips MC; Voorn GP; Souverein PC; Endeman H; Biesma DH; Leufkens HG; van de Garde EM Eur Respir J; 2011 Nov; 38(5):1165-72. PubMed ID: 21478217 [TBL] [Abstract][Full Text] [Related]
15. Proton pump inhibitors and hospitalization for Clostridium difficile-associated disease: a population-based study. Lowe DO; Mamdani MM; Kopp A; Low DE; Juurlink DN Clin Infect Dis; 2006 Nov; 43(10):1272-6. PubMed ID: 17051491 [TBL] [Abstract][Full Text] [Related]
16. Use of oral proton pump inhibitors is not associated with harm in patients with chronic heart failure in an ambulatory setting. Oudit GY; Bakal JA; McAlister FA; Ezekowitz JA Eur J Heart Fail; 2011 Nov; 13(11):1211-5. PubMed ID: 21831912 [TBL] [Abstract][Full Text] [Related]
17. Risk of hospitalization for acute pancreatitis associated with conventional and atypical antipsychotics: a population-based case-control study. Gasse C; Jacobsen J; Pedersen L; Mortensen PB; Nørgaard M; Sørensen HT; Johnsen SP Pharmacotherapy; 2008 Jan; 28(1):27-34. PubMed ID: 18154471 [TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitors and the risk of colorectal cancer. van Soest EM; van Rossum LG; Dieleman JP; van Oijen MG; Siersema PD; Sturkenboom MC; Kuipers EJ Am J Gastroenterol; 2008 Apr; 103(4):966-73. PubMed ID: 18070237 [TBL] [Abstract][Full Text] [Related]
19. Proton pump inhibitors reduce the long-term risk of recurrent upper gastrointestinal bleeding: an observational study. Massó González EL; García Rodríguez LA Aliment Pharmacol Ther; 2008 Sep; 28(5):629-37. PubMed ID: 18616644 [TBL] [Abstract][Full Text] [Related]